title: Long-term outcome of treatment with ruxolitinib in myelofibrosis.
authors: Ayalew
authors: A
authors: Tefferi
authors: Mark R
authors: MR
authors: Litzow
authors: Animesh
authors: A
authors: Pardanani
mesh_terms: D018450:Disease Progression; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000401:mortality; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines; D015996:Survival Rate
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases